EMERYVILLE, Calif., Oct. 14, 2011 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing non-antibiotic anti-infective agents for topical non-systemic applications, today announced the first introduction of NeutroPhase at the Symposium on Advanced Wound Care (SAWC) from October 13-15 at the Rio Hotel & Casino in Las Vegas, Nevada at booth #525.